| Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102) |
|---|
| 02/23/1999 | US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site |
| 02/09/1999 | US5869445 Methods for eliciting or enhancing reactivity to HER-2/neu protein |
| 12/23/1998 | EP0885904A1 Peptides as agonists and/or inhibitors of amyloid formation and/or cytotoxicity and their use against Alzheimer's disease, type II diabetes mellitus and spongiform encephalopathy |
| 12/17/1998 | CA2240005A1 Peptides acting as agonists and inhibitors of amyloid formation and cytotoxicity for therapeutic use with alzeheimer's disease, type ii diabetes mellitus and spongiform encephalopathies |
| 12/08/1998 | US5846538 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 12/03/1998 | WO1998054577A1 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
| 12/03/1998 | CA2290993A1 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
| 11/24/1998 | US5840526 Two heavy polypeptide chains with variable and constant regions including complete antigen binding sites; constant region lacks ch1 domain; increased ease of preparation by genetic engineering; medical diagnosis |
| 11/24/1998 | US5840340 Oligopeptides with fragrance, cosmetics and dye |
| 11/04/1998 | EP0875564A1 Biologically active extract from the leech 'Limnatis nilotica' |
| 10/20/1998 | US5824774 Chimeric isoprenoid synthases and uses thereof |
| 10/20/1998 | US5824640 Substances of polypeptide nature useful in human therapy |
| 09/23/1998 | EP0865292A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 09/15/1998 | US5808029 Genetic engineering |
| 09/11/1998 | CA2282827A1 Method of alleviating neuropathic pain |
| 09/09/1998 | EP0862448A1 Fine tuned protegrins |
| 09/01/1998 | US5801005 Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
| 09/01/1998 | US5800988 Cdna libraries with nucleotide sequences coded for immunoglobulins with polypeptide chains |
| 08/25/1998 | US5798444 Incorporating derivatives of 2,4,5-triaminopentanoic acid and aminoglutamic acid into peptide during solid phase synthesis |
| 08/18/1998 | US5795736 Peptide amino acid sequences, replacements and expression vectors |
| 07/21/1998 | US5783433 Ion exchanging |
| 07/07/1998 | US5776895 Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic shock |
| 07/02/1998 | WO1998027805A1 Antimicrobial proteins |
| 07/02/1998 | CA2274730A1 Antimicrobial proteins |
| 07/01/1998 | CN1186517A Altered polypeptides with increased half-life |
| 06/16/1998 | US5766927 Stabilizing the protein by contacting the cell with a dipeptide having an n-terminal amino acid residue selected form the group consists of arginine, lysins and histidine |
| 06/16/1998 | US5766850 Human β2 integrin α subunit |
| 06/02/1998 | US5759808 Immunoglobulins devoid of light chains |
| 05/27/1998 | CN1183117A Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/12/1998 | US5750654 Leukaemia inhibitory factor |
| 05/12/1998 | US5750503 Administering synergistic mixture of granulocyte colony stimulating factor (g-csf) and tumor necrosis factor binding protein (tnf-bp) lacking first domain of constant region of heavy chain of human immunoglobulin igg1 or igg3 |
| 05/07/1998 | WO1998009985A3 Anti-inflammatory peptides and uses thereof |
| 04/30/1998 | WO1998017301A1 Peptides for inhibiting retroviruses |
| 04/30/1998 | CA2272601A1 Peptides for inhibiting retroviruses |
| 03/31/1998 | US5734011 Ligand precursors for incorporation into peptides |
| 03/25/1998 | EP0830603A1 Compositions and methods of using terminally labeled peptides that bind mhc class i molecules |
| 03/12/1998 | WO1998009985A2 Anti-inflammatory peptides and uses thereof |
| 03/12/1998 | WO1998009984A1 Central nervous system-derived immune privilege factor and uses thereof |
| 03/12/1998 | WO1997046259A3 Chimeric toxin for targeted therapy |
| 03/12/1998 | CA2264959A1 Central nervous system-derived immune privilege factor and uses thereof |
| 03/12/1998 | CA2264285A1 Anti-inflammatory peptides and uses thereof |
| 03/10/1998 | US5726023 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/03/1998 | US5723504 Amadori reaction compounds and products, process for their manufacture, and their use as cytokine inducers |
| 02/12/1998 | WO1998005348A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
| 02/05/1998 | WO1998004278A2 Tetrapeptide derivatives of dolastatin as antitumor agents |
| 02/04/1998 | EP0821732A1 Altered polypeptides with increased half-life |
| 01/14/1998 | EP0817846A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 12/24/1997 | CN1168699A Protein kinase NPK-llo |
| 12/18/1997 | WO1997047644A1 T cell antigen receptor peptides |
| 12/11/1997 | WO1997046259A2 Chimeric toxin for targeted therapy |
| 12/03/1997 | EP0600866B1 Compositions and methods for identifying biologically active molecules |
| 11/06/1997 | WO1997035969A3 Peptide ligands of the urokinase receptor |
| 10/23/1997 | WO1997038703A1 Chimeric isoprenoid synthases and uses thereof |
| 10/02/1997 | WO1997035969A2 Peptide ligands of the urokinase receptor |
| 09/16/1997 | US5667811 Na-K-ATPase inhibiting natriuretic substances |
| 08/27/1997 | EP0791067A2 Protein kinase npk-110 |
| 08/20/1997 | CN1157620A Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 07/23/1997 | EP0662135B1 Alteration of polypeptides |
| 07/15/1997 | CA2063400C Inhibition of the n-end rule pathway in living cells |
| 06/24/1997 | US5641485 Caledothricins used in the treatment mycotic diseases |
| 06/03/1997 | US5635484 Propionibacteria peptide microcin |
| 05/29/1997 | WO1997018827A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/29/1997 | CA2238429A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/13/1997 | US5628979 Reagent for tumor imaging and therapy |
| 05/07/1997 | EP0771323A1 Corticotropin-releasing factor-binding-protein inhibitors and their use |
| 05/02/1997 | EP0770091A1 Compounds for reversing drug resistance |
| 04/22/1997 | US5622933 Multiple branch peptide constructions for use against HIV |
| 03/25/1997 | CA1339015C Macrocyclic chelates and methods of use thereof |
| 03/18/1997 | US5612042 Vaccine against streptococcus suis infection |
| 03/11/1997 | US5610279 Human TNF receptor |
| 02/26/1997 | EP0697884A4 Ligand precursors for incorporation into peptides |
| 02/12/1997 | CN1142503A Preparation of natural medical polymer materials |
| 02/05/1997 | CN1142230A Antibiotic stalobacins |
| 02/05/1997 | CN1033976C Preparation of polypeptides used as blockers of calcium channels |
| 02/04/1997 | CA2071425C Prophylactic/therapeutic composition for disseminated intravascular coagulation, or chronic respiratory tract infectious disease |
| 01/03/1997 | WO1997000081A1 A method for inhibiting bacteremia and bacterial dissemination |
| 01/03/1997 | CA2361012A1 Conformationally-restricted combinatorial library composition and method |
| 12/19/1996 | WO1996041188A1 Compositions and methods of using terminally labeled peptides that bind mhc class i molecules |
| 12/18/1996 | EP0748335A1 Antibiotic stalobacins |
| 12/10/1996 | US5583200 Containing magnesium or calcium ions; storage stability; immunoassay for myocardial infarction |
| 12/03/1996 | CA2115461C Enzymatic analysis using substrates that yield fluorescent precipitates |
| 11/26/1996 | US5578323 Proteinoid carriers and methods for preparation and use thereof |
| 11/06/1996 | CN1135237A Products that elicit neutralizing antibodies against genetically divergent HIV-1 strains |
| 11/05/1996 | US5571701 Antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 10/23/1996 | EP0641351B1 Enzymatic analysis using substrates that yield fluorescent precipitates |
| 10/17/1996 | WO1996032478A1 Altered polypeptides with increased half-life |
| 10/03/1996 | WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 09/24/1996 | CA2026418C Polypeptides useful as blockers of calcium channels |
| 09/10/1996 | US5554375 Hair growth |
| 09/04/1996 | CN1130028A Method for preparing phycocyan |
| 08/20/1996 | US5547846 Immunogenic regions on the E7 protein of human papillomavirus type 16 |
| 08/15/1996 | WO1996013590A3 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |
| 08/14/1996 | EP0725825A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 08/01/1996 | WO1996013592A3 Protein kinase npk-110 |
| 07/17/1996 | EP0721464A1 Neuron regulatory factor for promoting neuron survival |
| 07/02/1996 | US5532339 Fusion protein between human macif and a heterologous pi anchor domain |
| 05/29/1996 | CN1031892C Expression of human proapolipoprotein A-I |
| 05/09/1996 | WO1996013592A2 Protein kinase npk-110 |
| 05/09/1996 | WO1996013590A2 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |
| 05/09/1996 | CA2203910A1 Novel protein kinase (npk-110) |